Dopamine recalls

The FDA has published 2 recalls involving Dopamine since 2014. The latest was reported on 23 Sep 2026. Most were for sterility. Pfizer has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2014

Last 12 months1reported

Class I00% of total

Ongoing1latest 23 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 1 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why dopamine is recalled

Sterility2100%

Companies

Pfizer150%
Baxter Healthcare150%

Brands

By year

2026150%
2014150%

Ongoing dopamine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Dopamine HCl Inj., USP, 200 mg/ (40 mg/mL) Single-dose recalledDopamine Hydrochloride	Pfizer	Sterility	Nationwide

All dopamine recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Dopamine HCl Inj., USP, 200 mg/ (40 mg/mL) Single-dose recalledDopamine Hydrochloride	Pfizer	Sterility	Nationwide
8 Oct 2014Drug	CLASS II	DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg recalledDopamine Hydrochloride And Dextrose	Baxter Healthcare	Sterility	Nationwide

Should you stop taking Dopamine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.